🇨🇦 Canada Country × Condition
atrial fibrillation af Clinical Trials in Canada
Active clinical trials for atrial fibrillation af with research sites in Canada. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇨🇦 Canada
Active Trials in Canada (3)
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Enrollment
1,200 pts
Country
🇨🇦 Canada
Regeneron Pharmaceuticals
View Trial → NCT06957366
Recruiting
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Enrollment
920 pts
Country
🇨🇦 Canada
McMaster University
View Trial → NCT07272902
Recruiting
Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication
Enrollment
84 pts
Country
🇨🇦 Canada
Nova Scotia Health Authority
View Trial → Frequently Asked Questions
How many atrial fibrillation af clinical trials are active in Canada?
There are currently 3 active clinical trials for atrial fibrillation af with sites in Canada, of which 3 are actively recruiting patients.
How can I join a atrial fibrillation af clinical trial in Canada?
To join a atrial fibrillation af clinical trial in Canada, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Canada directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are atrial fibrillation af trials in Canada?
Active atrial fibrillation af trials in Canada span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.